<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The occurrence of therapy-related <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) is rare and, to our knowledge, is not reported in patients treated for Burkitt's <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report on a child with ALL with translocation t(4;11)(q21;q23) involving the MLL gene, 13 months after chemotherapy for Burkitt's <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This present observation indicates that caution should be exercised in using high cumulative doses of DNA <z:chebi fb="0" ids="50750">topoisomerase II inhibitors</z:chebi> in such patients </plain></SENT>
</text></document>